Concorde Financial’s CVS Health CVS Stock Holding History

Concorde Financial’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-605	Closed	-$57.7K	–	38
2022 Q4	$57.7K	Hold	605	–	–	0.04%	44
2022 Q3	$58K	Buy	+605	New	+$59.9K	0.04%	44
2022 Q1	–	Sell	-505	Closed	-$53K	–	78
2021 Q4	$53K	Buy	+505	New	+$46.7K	0.03%	53

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Concorde Financial's CVS Position: Q1 2023 in Review

Concorde Financial sold out of CVS Health (CVS) in Q1 2023, closing a stake of 605 shares — an estimated $57.7K sold.

Concorde Financial first reported a position in CVS in Q4 2021 and held it in 3 quarters. The position peaked at $58K in Q3 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Concorde Financial reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Concorde Financial sold 605 CVS Health shares in Q1 2023, an estimated $57.7K.
Concorde Financial first reported a position in CVS Health in Q4 2021 and held it in 3 quarters.
Concorde Financial's CVS Health position peaked at $58K in Q3 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Concorde Financial's 13F filing for Q1 2023, filed 10 May 2023.